Pancreatic Cancer Research

ResearcherNingbo University Affiliated HospitalActive in the last 2 years

Liping Ying

ORCID-verified (high confidence)As of 14 November 2026

Matched on ORCID iD 0000-0002-0158-6424; OpenAlex author ID A5008522075.

Their work

Counts cover pancreatic cancer work only: a researcher’s other papers, trials and grants are not in these records.

Pancreatic cancer papers
2 (first author 1, last author 0)
Pancreatic cancer trials
0
Pancreatic cancer grants
0
Collaborators
3
Papers, trials and grants by year

2023: 1 paper · 2024: none · 2025: none · 2026: 1 paper

Papers 2

  1. ST8SIA4-mediated N-glycosylation of hENT1 suppresses gemcitabine resistance in pancreatic cancer. Co-author DOI 10.1515/znc-2025-0168↗
  2. Long non-coding RNA SNHG17 contributes to the progression of pancreatic adenocarcinoma by modulating miR-32-5p/EZH2/STAT3 signaling. First author DOI 10.1007/s11033-023-08530-1↗

Closest collaborators

The 3 strongest of 3 ranked by shared papers, trials and grants, with recent and small-team work weighing most.

  1. Nengyun Zhang · 1 shared paper, 2026
  2. Chang Xin · 1 shared paper, 2026
  3. Zongyang Wu · 1 shared paper, 2023

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (the fewest links first, then the links with the most shared work). Built from public records only; no contact details are kept.